vs
Side-by-side financial comparison of Mama's Creations, Inc. (MAMA) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $47.3M, roughly 1.8× Mama's Creations, Inc.). Mama's Creations, Inc. runs the higher net margin — 1.1% vs -38.1%, a 39.2% gap on every dollar of revenue. On growth, Mama's Creations, Inc. posted the faster year-over-year revenue change (50.0% vs 20.2%). Over the past eight quarters, Mama's Creations, Inc.'s revenue compounded faster (33.0% CAGR vs 24.8%).
Mama's Creations, Inc. is a U.S.-based food manufacturing enterprise that produces a wide portfolio of refrigerated ready-to-eat and heat-and-serve food products, including Italian-style meatballs, sausages, pasta dishes, and other prepared meals. It mainly distributes its offerings to grocery retailers, mass merchandisers and foodservice partners across the United States, focusing on convenient, high-quality comfort food for daily consumer demand.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
MAMA vs PRCT — Head-to-Head
Income Statement — Q3 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $47.3M | $83.1M |
| Net Profit | $540.0K | $-31.6M |
| Gross Margin | 23.6% | 64.9% |
| Operating Margin | 1.7% | -4.1% |
| Net Margin | 1.1% | -38.1% |
| Revenue YoY | 50.0% | 20.2% |
| Net Profit YoY | 31.7% | -27.9% |
| EPS (diluted) | $0.01 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $47.3M | $76.4M | ||
| Q3 25 | $35.2M | $83.3M | ||
| Q2 25 | $35.3M | $79.2M | ||
| Q1 25 | $33.6M | $69.2M | ||
| Q4 24 | $31.5M | $68.2M | ||
| Q3 24 | $28.4M | $58.4M | ||
| Q2 24 | $29.8M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $540.0K | $-29.8M | ||
| Q3 25 | $1.3M | $-21.4M | ||
| Q2 25 | $1.2M | $-19.6M | ||
| Q1 25 | $1.6M | $-24.7M | ||
| Q4 24 | $410.0K | $-18.9M | ||
| Q3 24 | $1.1M | $-21.0M | ||
| Q2 24 | $553.0K | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | 23.6% | 60.6% | ||
| Q3 25 | 24.9% | 64.8% | ||
| Q2 25 | 26.1% | 65.4% | ||
| Q1 25 | 27.0% | 63.9% | ||
| Q4 24 | 22.6% | 64.0% | ||
| Q3 24 | 24.2% | 63.2% | ||
| Q2 24 | 25.0% | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 1.7% | -40.6% | ||
| Q3 25 | 4.8% | -27.8% | ||
| Q2 25 | 4.5% | -28.0% | ||
| Q1 25 | 5.7% | -39.7% | ||
| Q4 24 | 1.8% | -28.9% | ||
| Q3 24 | 5.7% | -38.4% | ||
| Q2 24 | 2.6% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 1.1% | -39.1% | ||
| Q3 25 | 3.6% | -25.7% | ||
| Q2 25 | 3.5% | -24.7% | ||
| Q1 25 | 4.8% | -35.8% | ||
| Q4 24 | 1.3% | -27.6% | ||
| Q3 24 | 4.0% | -35.9% | ||
| Q2 24 | 1.9% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.01 | $-0.54 | ||
| Q3 25 | $0.03 | $-0.38 | ||
| Q2 25 | $0.03 | $-0.35 | ||
| Q1 25 | $0.04 | $-0.45 | ||
| Q4 24 | $0.01 | $-0.34 | ||
| Q3 24 | $0.03 | $-0.40 | ||
| Q2 24 | $0.01 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.1M | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $49.6M | $347.7M |
| Total Assets | $84.0M | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $18.1M | $286.5M | ||
| Q3 25 | $9.4M | $294.3M | ||
| Q2 25 | $12.0M | $302.7M | ||
| Q1 25 | $7.2M | $316.2M | ||
| Q4 24 | $9.3M | $333.7M | ||
| Q3 24 | $7.4M | $196.8M | ||
| Q2 24 | $13.0M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $49.6M | $365.9M | ||
| Q3 25 | $29.6M | $380.3M | ||
| Q2 25 | $26.4M | $385.8M | ||
| Q1 25 | $24.9M | $389.2M | ||
| Q4 24 | $23.0M | $402.2M | ||
| Q3 24 | $22.3M | $241.2M | ||
| Q2 24 | $20.3M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $84.0M | $508.1M | ||
| Q3 25 | $51.2M | $511.5M | ||
| Q2 25 | $52.7M | $513.1M | ||
| Q1 25 | $47.1M | $519.4M | ||
| Q4 24 | $47.9M | $534.0M | ||
| Q3 24 | $43.0M | $374.1M | ||
| Q2 24 | $47.2M | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.9M | — |
| Free Cash FlowOCF − Capex | $3.7M | — |
| FCF MarginFCF / Revenue | 7.8% | — |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | 7.16× | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $3.9M | $-10.3M | ||
| Q3 25 | $-1.7M | $-6.6M | ||
| Q2 25 | $6.0M | $-15.0M | ||
| Q1 25 | $-857.0K | $-17.0M | ||
| Q4 24 | $4.8M | $-32.4M | ||
| Q3 24 | $-2.4M | $-18.8M | ||
| Q2 24 | $3.6M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $3.7M | $-12.2M | ||
| Q3 25 | $-2.2M | $-9.5M | ||
| Q2 25 | $5.5M | $-17.8M | ||
| Q1 25 | $-930.0K | $-18.8M | ||
| Q4 24 | $2.5M | $-33.6M | ||
| Q3 24 | $-4.0M | $-19.0M | ||
| Q2 24 | $2.5M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | 7.8% | -15.9% | ||
| Q3 25 | -6.2% | -11.4% | ||
| Q2 25 | 15.5% | -22.5% | ||
| Q1 25 | -2.8% | -27.2% | ||
| Q4 24 | 8.0% | -49.2% | ||
| Q3 24 | -14.1% | -32.6% | ||
| Q2 24 | 8.4% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | 2.4% | ||
| Q3 25 | 1.5% | 3.4% | ||
| Q2 25 | 1.5% | 3.5% | ||
| Q1 25 | 0.2% | 2.7% | ||
| Q4 24 | 7.2% | 1.7% | ||
| Q3 24 | 5.6% | 0.4% | ||
| Q2 24 | 3.8% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 7.16× | — | ||
| Q3 25 | -1.31× | — | ||
| Q2 25 | 4.85× | — | ||
| Q1 25 | -0.54× | — | ||
| Q4 24 | 11.71× | — | ||
| Q3 24 | -2.10× | — | ||
| Q2 24 | 6.58× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MAMA
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
